<DOC>
	<DOCNO>NCT00935675</DOCNO>
	<brief_summary>Evaluation effectiveness escitalopram depressive symptom 3 month patient head neck squamous cell carcinoma ( oral cavity , larynx , oropharynx hypopharynx ) HADS total score &gt; 11</brief_summary>
	<brief_title>Double-blind , Placebo-controlled , Randomized Study Effectiveness Escitalopram Emotional Distress Head Neck Cancer Patients During Cancer Treatment</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 . Head neck squamous cell carcinoma , stage I IVb 2 . Firstline curative cancer therapy : surgery and/or brachytherapy and/or chemotherapy 3 . HADS T &gt; 11 4 . Aged 18 75 yo , write consent require 5 . OMS &gt; 2 1 . Palliative care 2 . Previous head neck cancer 3 . Bipolar disorder schizophrenia 4 . Severe major depressive disorder ( DSMIV TR ) 5 . Expressed suicidal ideation 6 . Severe untreated organic disorder , especially acute infectious disorder 7 . ASAT/ALAT &gt; 3N 8 . Clearance creatinin &lt; 30 ml/mn 9 . Hyponatremia 10 . Antecedent delirium tremens acute alcohol withdrawal disorder 11 . Antecedent upper gastrointestinal bleeding 12 . Antecedent toxicity inefficacy previous treatment escitalopram 13 . Unauthorized treatment : Antidepressant antiepileptic ( clonazepam authorize ) Hypnotic except zolpidem Anxiolytic except clonazepam , clorazepate diazepam bupropion varenicline 14 . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Patients head neck squamous cell carcinoma</keyword>
	<keyword>head neck squamous cell carcinoma</keyword>
</DOC>